Product NDC: | 0574-0163 |
Proprietary Name: | Lorazepam |
Non Proprietary Name: | Lorazepam |
Active Ingredient(s): | 2 mg/mL & nbsp; Lorazepam |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0574-0163 |
Labeler Name: | Paddock Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079244 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090401 |
Package NDC: | 0574-0163-30 |
Package Description: | 1 BOTTLE in 1 CARTON (0574-0163-30) > 30 mL in 1 BOTTLE |
NDC Code | 0574-0163-30 |
Proprietary Name | Lorazepam |
Package Description | 1 BOTTLE in 1 CARTON (0574-0163-30) > 30 mL in 1 BOTTLE |
Product NDC | 0574-0163 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lorazepam |
Dosage Form Name | SOLUTION, CONCENTRATE |
Route Name | ORAL |
Start Marketing Date | 20090401 |
Marketing Category Name | ANDA |
Labeler Name | Paddock Laboratories, Inc. |
Substance Name | LORAZEPAM |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |